Related Experiment Video
Updated: Dec 4, 2025
10:39
Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning
Published on: August 29, 2025
797
An instrument for evaluating the clinical applicability of guidelines
Zeng Linan1,2, Yi Qiusha1,2,3, Zhang Chuan1,2
1Department of Pharmacy/Evidence-Based Pharmacy Centre, West China Second University Hospital, Sichuan University, Chengdu, P.R. China.
Journal of Evidence-Based Medicine
|October 22, 2020
Summary
A new instrument helps evaluate clinical guideline applicability from the user
Area of Science:
- Clinical Practice Guidelines
- Health Services Research
- Medical Informatics
Background:
- Clinical guidelines are crucial for evidence-based practice, but their real-world applicability is often suboptimal.
- Evaluating guideline applicability from the perspective of end-users (clinicians) is essential for successful implementation.
Purpose of the Study:
- To develop and validate an instrument for assessing the clinical applicability of guidelines from the perspective of guideline users.
Main Methods:
- Instrument development involved a working group, qualitative systematic review for item generation, and two rounds of modified Delphi surveys.
- External review was conducted to refine the initial instrument.
- The instrument development process ensured predefined requirements for appraisal aspects and items were met.
Main Results:
- The developed instrument comprises three sections: evaluator information (12 items), clinical applicability evaluation (12 items), and a scoring scheme.
- The clinical applicability section assesses availability, readability, acceptability, feasibility, and overall applicability of guidelines.
Conclusions:
- The new instrument provides a standardized method for evaluating guideline clinical applicability from the user's viewpoint.
- This tool can inform guideline development and updates to enhance their practical use in clinical settings.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
284
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
284
01:16Clinical Trials
10.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.0K
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
99
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
99
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
77
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
77
01:11Clinical Trials: Overview
4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
01:19Guidelines For Measuring Vital Signs
2.5K
Following these guidelines can help nurses accurately measure vital signs, assess changes in patient conditions, and provide timely treatment when necessary. Adhering closely to the guidelines ensures the accuracy and reliability of the results.
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.
2.5K